Zynex Kiemelkedően
Mi az Zynex Kiemelkedően?
A Kiemelkedően az Zynex, Inc. - 40.099M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a XETRA-on cégekben a Zynex -hoz képest
Mit csinál Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
kiemelkedően -hoz hasonló cégek Zynex
- Kiadis Pharma NV nak Kiemelkedően 40.042M van
- Minto Apartment Real Estate Investment Trust nak Kiemelkedően 40.070M van
- Pool Dl ,001 nak Kiemelkedően 40.088M van
- Dorchester Minerals LP nak Kiemelkedően 40.089M van
- The Byke Hospitality nak Kiemelkedően 40.098M van
- The Byke Hospitality nak Kiemelkedően 40.098M van
- Zynex nak Kiemelkedően 40.099M van
- Skywest nak Kiemelkedően 40.104M van
- Margaux Resources nak Kiemelkedően 40.107M van
- Cassiar Gold Corp nak Kiemelkedően 40.107M van
- Quartz Mountain Resources nak Kiemelkedően 40.114M van
- Alterity Therapeutics nak Kiemelkedően 40.115M van
- Wereldhave N.V nak Kiemelkedően 40.125M van